Overview

Treatment of Hypoparathyroidism With Subcutaneous PTH (1-84) Injections: Effects on Muscle Function and Quality of Life

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to assess whether PTH (1-84) therapy posses advantages compared to conventional treatment in patients with hypoparathyroidism on muscle function, quality of life, calcium homeostasis, bone metabolism, and body composition.
Phase:
Phase 2
Details
Lead Sponsor:
University of Aarhus
Treatments:
Parathyroid Hormone